About GW Pharma
GW Pharma is a company based in Cambridge (United Kingdom) founded in 1998 was acquired by Jazz Pharmaceuticals in February 2021.. GW Pharma has raised $46.5 million across 3 funding rounds from investors including Jazz Pharmaceuticals and Mentor Capital. GW Pharma offers products and services including Xywav, Epidiolex, Defitelio, and Rylaze. GW Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, PureTech Health and Biohaven Pharmaceutical, among others.
- Headquarter Cambridge, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gw Pharma Limited
- Date of Incorporation 29 Jan, 1999
- Jurisdiction CAMBRIDGE
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$46.5 M (USD)
in 3 rounds
-
Latest Funding Round
$1 M (USD), Post-IPO
Mar 03, 2017
-
Investors
Jazz Pharmaceuticals
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Jazz Pharmaceuticals
(Feb 03, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GW Pharma
GW Pharma offers a comprehensive portfolio of products and services, including Xywav, Epidiolex, Defitelio, and Rylaze. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Oral solution for treating narcolepsy and idiopathic hypersomnia
Cannabidiol-based treatment for epilepsy seizures
Therapy for preventing complications in leukemia patients
Recombinant treatment for acute lymphoblastic leukemia
Unlock access to complete
Unlock access to complete
Leadership Team
223 people
Software Development Team
103 people
Sales and Marketing
70 people
Senior Team
66 people
Product Management Team
56 people
Finance and Accounting
37 people
Data Analysis and Operations Team
31 people
Human Resources and Administration
30 people
Unlock access to complete
Funding Insights of GW Pharma
GW Pharma has successfully raised a total of $46.5M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $1.0M
-
First Round
First Round
(01 Jun 2003)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2017 | Amount | Post-IPO - GW Pharma | Valuation |
investors |
|
| Jan, 2006 | Amount | Series C - GW Pharma | Valuation |
investors |
|
| Jun, 2003 | Amount | Series C - GW Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GW Pharma
GW Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Jazz Pharmaceuticals and Mentor Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Energy investments and funding for pre-IPO companies in oil, gas, coal, and uranium sectors.
|
Founded Year | Domain | Location | |
|
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GW Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GW Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gw Pharma Comparisons
Competitors of GW Pharma
GW Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, PureTech Health and Biohaven Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Drugs for CNS disorders are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for psychosis and cognitive impairment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gw Pharma
Frequently Asked Questions about GW Pharma
When was GW Pharma founded?
GW Pharma was founded in 1998 and raised its 1st funding round 5 years after it was founded.
Where is GW Pharma located?
GW Pharma is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is GW Pharma a funded company?
GW Pharma is a funded company, having raised a total of $46.5M across 3 funding rounds to date. The company's 1st funding round was a Series C of $31.5M, raised on Jun 01, 2003.
What does GW Pharma do?
GW Pharma was founded in 1998 in Cambridge, United Kingdom, within the pharmaceutical sector. Focus is placed on developing cannabinoid-based treatments, including Sativex for managing spasticity in multiple sclerosis patients and pain in cancer cases, as well as Epidiolex for addressing epilepsy in children. Operations center on research and drug approval processes across Europe and beyond, targeting neurological and pain-related conditions.
Who are the top competitors of GW Pharma?
GW Pharma's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does GW Pharma offer?
GW Pharma offers Xywav, Epidiolex, Defitelio, and Rylaze.
Who are GW Pharma's investors?
GW Pharma has 2 investors. Key investors include Jazz Pharmaceuticals, and Mentor Capital.